Radiology, Vol 196, 439-443, Copyright © 1995 by Radiological Society of North America

ARTICLES

Clinical safety of gadopentetate dimeglumine

KL Nelson, LM Gifford, C Lauber-Huber, CA Gross and TA Lasser
Department of Radiology, Omaha, NE 68105, USA.

PURPOSE: To quantify the rate of adverse reactions to gadopentetate dimeglumine. MATERIALS AND METHODS: Magnetic resonance (MR) imaging was performed in 15,496 patients in April-September 1992. Data were collected before and after intravenous administration of 0.1 mmol/kg gadopentetate dimeglumine. RESULTS: Adverse reactions occurred in 2.4% (n = 372) of patients. Symptoms abated the same or next day in 94.1% (n = 350). Whereas onset occurred within 30 minutes after injection in 49.7% (n = 185), onset occurred more than 1 hour after injection in 44.9% (n = 167). Two serious adverse reactions occurred and were attributed to underlying disease. The rate of adverse reaction was 3.7% in patients with a history of asthma (31 of 831 patients) or allergy (144 of 3,860 patients). Patients with previous reactions to an MR imaging or iodinated contrast agent had an adverse-reaction rate in this study of 21.3% (16 of 75) and 6.3% (54 of 857), respectively. The rate of adverse reaction was 2.2% when gadopentetate dimeglumine was administered slowly and 2.9% when it was administered rapidly. CONCLUSION: Findings confirm the safety of gadopentetate dimeglumine.

This article has been cited by other articles:

				P. M. Colletti Nephrogenic Systemic Fibrosis and Gadolinium: A Perfect Storm Am. J. Roentgenol., October 1, 2008; 191(4): 1150 - 1153. [Full Text] [PDF]

				M Fenchel, A Franow, P Martirosian, M Engels, U Kramer, N I Stauder, U Helber, H Vogler, C D Claussen, and S Miller 1 M Gd-chelate (gadobutrol) for multislice first-pass magnetic resonance myocardial perfusion imaging Br. J. Radiol., November 1, 2007; 80(959): 884 - 892. [Abstract] [Full Text] [PDF]

				H. Ersoy, S. Z. Goldhaber, T. Cai, T. Luu, J. Rosebrook, R. Mulkern, and F. Rybicki Time-Resolved MR Angiography: A Primary Screening Examination of Patients with Suspected Pulmonary Embolism and Contraindications to Administration of Iodinated Contrast Material Am. J. Roentgenol., May 1, 2007; 188(5): 1246 - 1254. [Abstract] [Full Text] [PDF]

				V. L. Wright, W. Olan, B. Dick, H. Yu, N. Alberts-Grill, L. L. Latour, and A. E. Baird Assessment of CE-MRA for the rapid detection of supra-aortic vascular disease Neurology, July 12, 2005; 65(1): 27 - 32. [Abstract] [Full Text] [PDF]

				C. Chicoskie and R. Tello Gadolinium-Enhanced MDCT Angiography of the Abdomen: Feasibility and Limitations Am. J. Roentgenol., June 1, 2005; 184(6): 1821 - 1828. [Abstract] [Full Text] [PDF]

				P. Haage, W. Piroth, G. Krombach, S. Karaagac, T. Schaffter, R. W. Gunther, and A. Bucker Pulmonary Embolism: Comparison of Angiography with Spiral Computed Tomography, Magnetic Resonance Angiography, and Real-Time Magnetic Resonance Imaging Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 729 - 734. [Abstract] [Full Text] [PDF]

				C. Rickers, M. Jerosch-Herold, X. Hu, N. Murthy, X. Wang, H. Kong, R. T. Seethamraju, J. Weil, and N. M. Wilke Magnetic Resonance Image-Guided Transcatheter Closure of Atrial Septal Defects Circulation, January 7, 2003; 107(1): 132 - 138. [Abstract] [Full Text] [PDF]

				A.-F. Le Blanche, M. Tassart, J.-F. Deux, J. Rossert, J.-M. Bigot, and F. Boudghene Gadolinium-Enhanced Digital Subtraction Angiography of Hemodialysis Fistulas: A Diagnostic and Therapeutic Approach Am. J. Roentgenol., October 1, 2002; 179(4): 1023 - 1028. [Abstract] [Full Text] [PDF]

				T K Mittal, C Evans, T Perkins, and A M Wood Renal arteriography using gadolinium enhanced 3D MR angiography--clinical experience with the technique, its limitations and pitfalls Br. J. Radiol., June 1, 2001; 74(882): 495 - 502. [Abstract] [Full Text] [PDF]

				K. U. Juergens, B. Tombach, P. Reimer, T. Vestring, and W. Heindel Three-Dimensional Contrast-Enhanced MR Angiography of Endovascular Covered Stents in Patients with Peripheral Arterial Occlusive Disease Am. J. Roentgenol., May 1, 2001; 176(5): 1299 - 1303. [Abstract] [Full Text] [PDF]

				R. R. Brown, D. W. Clarke, and R. H. Daffner Is a Mixture of Gadolinium and Iodinated Contrast Material Safe During MR Arthrography? Am. J. Roentgenol., October 1, 2000; 175(4): 1087 - 1090. [Abstract] [Full Text] [PDF]

				K. Bhirangi, M. Gilfeather, E. S. Siegelman, M. D. Schnall, G. A. Holland, J. P. Carpenter, and M. A. Golden Comparison of Preoperative Three-Dimensional Gadolinium-Enhanced Magnetic Resonance Imaging to the Operative Assessment of Abdominal Aortic Aneurysm Anatomy: A Retrospective Study Vascular and Endovascular Surgery, March 1, 2000; 34(2): 107 - 113. [Abstract] [PDF]

				M. B. J. M. Korst, F. B. M. Joosten, C. T. Postma, G. J. Jager, J. K. Krabbe, and J. O. Barentsz Accuracy of Normal-Dose Contrast-Enhanced MR Angiography in Assessing Renal Artery Stenosis and Accessory Renal Artery Stenosis and Accessory Renal Arteries Am. J. Roentgenol., March 1, 2000; 174(3): 629 - 634. [Abstract] [Full Text] [PDF]

				N. M. Rofsky and M. A. Adelman MR Angiography in the Evaluation of Atherosclerotic Peripheral Vascular Disease Radiology, February 1, 2000; 214(2): 325 - 338. [Abstract] [Full Text]

				P. R. Hilfiker, H. H. Quick, and J. F. Debatin Plain and Covered Stent-Grafts: In Vitro Evaluation of Characteristics at Three-dimensional MR Angiography Radiology, June 1, 1999; 211(3): 693 - 697. [Abstract] [Full Text]